Patents Assigned to Dow Pharmaceutical Sciences, Inc.
  • Controlled Release Azithromycin Solid Dosage Forms
    Publication number: 20120121702
    Abstract: A solid dosage form for oral administration comprising azithromycin in an amount below that which causes gastrointestinal side effects, which dosage form is a controlled release dosage form.
    Type: Application
    Filed: January 25, 2012
    Publication date: May 17, 2012
    Applicant: Dow Pharmaceutical Sciences, Inc.
    Inventors: Radhakrishnan Pillai, Pramod Sarpotdar, David W. Osborne, Gordon J. Dow
  • METHOD FOR OBTAINING A STABLE DISPERSION OF BENZOYL PEROXIDE
    Publication number: 20120115801
    Abstract: Powder containing benzoyl peroxide is readily wetted by contacting the powder with a liquid containing one or more of a polyol, a polyol, ether, and a low-carbon organic alcohol.
    Type: Application
    Filed: January 18, 2012
    Publication date: May 10, 2012
    Applicant: Dow Pharmaceutical Sciences, Inc.
    Inventor: Gordon Jay Dow
  • Azithromycin for treatment of skin disorders
    Patent number: 8143227
    Abstract: Azithromycin has increased efficacy in treating acne and other skin conditions when administered systemically at low doses, below those previously known to produce a clinical antibiotic effect.
    Type: Grant
    Filed: September 4, 2008
    Date of Patent: March 27, 2012
    Assignee: Dow Pharmaceutical Sciences, Inc.
    Inventors: Gordon Jay Dow, Bhaskar Chaudhuri, David Wade Osborne, Barry Calvarese
  • Controlled release azithromycin solid dosages forms
    Patent number: 8124123
    Abstract: A solid dosage form for oral administration comprising azithromycin in an amount below that which causes gastrointestinal side effects, which dosage form is a controlled release dosage form.
    Type: Grant
    Filed: December 17, 2007
    Date of Patent: February 28, 2012
    Assignee: Dow Pharmaceutical Sciences, Inc.
    Inventors: Radhakrishnan Pillai, Pramod Sarpotdar, David W. Osborne, Gordon J. Dow
  • Compositions and methods for treating diseases of the nail
    Publication number: 20120010246
    Abstract: Methods and compositions for treating disorders of the nail and nail bed. Such compositions contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, which composition has a surface tension of 40 dynes/cm or less and has continuing spreadability, and which composition is effective in treating a disorder of the nail or nail bed.
    Type: Application
    Filed: September 7, 2011
    Publication date: January 12, 2012
    Applicant: Dow Pharmaceutical Sciences, Inc.
    Inventors: Gareth Winckle, Gregory T. Fieldson
  • Compositions and methods for treating diseases of the nail
    Patent number: 8039494
    Abstract: Methods and compositions for treating disorders of the nail and nail bed. Such compositions contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, which composition has a surface tension of 40 dynes/cm or less and has continuing spreadability, and which composition is effective in treating a disorder of the nail or nail bed.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: October 18, 2011
    Assignee: Dow Pharmaceutical Sciences, Inc.
    Inventors: Gareth Winckle, Gregory T. Fieldson
  • Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
    Patent number: 7893097
    Abstract: The combination of any two of a polyol, a polyol ether, and a low carbon organic alcohol provides a synergistic effect on the solubility of azole compounds, such as metronidazole, in aqueous fluid.
    Type: Grant
    Filed: February 2, 2008
    Date of Patent: February 22, 2011
    Assignee: Dow Pharmaceutical Sciences, Inc.
    Inventors: Meidong Yang, Haigang Chen